Glaxosmithkline PLC Ord 25P (GSK)

Related News

28-Apr-2021 01:36 PM

GSK sales slide 18% in Q1

GlaxoSmithKline recorded £7.4 billion of sales in the first quarter, an 18 per cent drop from the same period in 2020. Turnover was impacted due to Covid-19 disruption but the company's management insists the long-term strategy remains on cour

23-Apr-2021 03:22 PM

EU approves GlaxoSmithKline's first anti-PD-1 therapy for endometrial cancer

GlaxoSmithKline (GSK) has announced the European Commission has granted conditional marketing authorisation for JEMPERLI (dostarlimab), a programmed death receptor-1 (PD-1)-blocking antibody, for use in women with mismatch repair-deficient (dMMR)/microsat

24-Mar-2021 02:31 PM

Moncef Slaoui departs Galvani Bioelectronics board of directors

The board of directors of GlaxoSmithKline, the majority shareholder of Galvani Bioelectronics, has announced the termination of Moncef Slaoui as chair of the Galvani board of directors, effective immediately. The termination follows the receipt of a lett

09-Mar-2021 02:18 PM

GSK reports rise in turnover

GlaxoSmithKline (GSK) has reported a slight increase in its annual group turnover to £34.1 billion in 2020 as operating profit hit close to £7.8 billion. Over the 12 months to the end of December 2020, the group had strong sales across key g

22-Feb-2021 01:48 PM

Sanofi and GSK initiate Phase 2 study of protein-based Covid vaccine

Sanofi and GSK have initiated a new Phase 2 study of their 'adjuvanted recombinant' protein-based COVID-19 vaccine candidate The Phase 2 study will assess the potential for refined antigen formulation to achieve optimal immune response, includi

12-Nov-2020 02:58 PM

GSK, Medicago launch trials of Covid-19 vaccine candidate

Pharmaceutical giant GSK and Canadian biopharmaceutical firm Medicago have announced the start of phase 2 and 3 clinical trials of a Covid-19 vaccine candidate. The trials will seek to evaluate the potential vaccine's efficacy, safety and its abilit

09-Nov-2020 08:05 AM

GlaxoSmithKline HIV drug cabotegravir superior to oral standard care

Glaxo's specialist HIV company ViiV Healthcare reported that interim analysis from the HPTN 084 study shows long-acting injectable cabotegravir administered every two months is 89% more effective than daily pills in preventing HIV in women. This fol

28-Oct-2020 01:17 PM

GlaxoSmithKline expects annual earnings at lower end of guidance range

Pharmaceutical company GlaxoSmithKline warned that it expected to post annual earnings at the lower end of its guidance range after its operating profit fell 13% in the third quarter. The company said it expected adjusted earnings per share for the year

28-Oct-2020 12:06 PM

FTSE 100 stabilises but still down more than 1.5% amid Covid fears

FTSE 100 stabilises but still down more than 1.5% amid Covid fears The FTSE 100 was down 1.7% to 5,629.42, off its six-month lows from this morning but still heavily in negative territory as investors weigh news of further national lockdowns across Europ

01-Sep-2020 09:20 AM

Broker Forecast - Morgan Stanley issues a broker note on GlaxoSmithKline PLC

Morgan Stanley today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1725p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...

12-Aug-2020 09:40 AM

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1800p (from 1920p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...

31-Jul-2020 12:00 PM

Broker Forecast - DZ Bank issues a broker note on GlaxoSmithKline PLC

DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1850p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...

31-Jul-2020 11:50 AM

Broker Forecast - Goldman Sachs issues a broker note on GlaxoSmithKline PLC

Goldman Sachs today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2020p (from 2060p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...

31-Jul-2020 08:10 AM

Broker Forecast - Credit Suisse issues a broker note on GlaxoSmithKline PLC

Credit Suisse today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1860p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...

29-Jul-2020 01:22 PM

GlaxoSmithKline adjusted earnings slump on lower vaccine sales

Pharmaceutical company GlaxoSmithKline said that meeting its annual earnings guidance was contingent on the timing of a recovery in vaccine demand, a slump in which drove a fall in its second-quarter sales. The company reported a more than doubling in pr

22-Jun-2020 12:10 PM

25-Jun-2021	Company Events - Today's Events
25-Jun-2021	Company Events - 7 Days Ahead Events
25-Jun-2021	Company Events - Month Ahead Events

04:43 pm	LPA Group PLC (LPA)
01:05 pm	Oxford Biomedica PLC (OXB)
07:00 am	Personal Group (PGH)
01:45 pm	Quartix Technologies (QTX)
04:21 pm	Accsys Technologies (AXS)
02:23 pm	Mortgage Adv Bureau (MAB1)
05:48 pm	GB Group PLC (GBG)
03:50 pm	PressureTechnologies (PRES)
05:09 pm	Springfield Props. (SPR)

Glaxosmithkline PLC Ord 25P (GSK)

Related News

Other FE fundinfo sites